Abstract:BackgroundThe RNA modification 5-methylcytosine (m5C) is one of the most prevalent post-transcriptional modifications, with increasing evidence demonstrating its extensive involvement in the tumorigenesis and progression of various cancers. Colorectal cancer (CRC) is the third most common cancer and second leading cause of cancer-related deaths worldwide. However, the role of m5C modulators in shaping tumor microenvironment (TME) heterogeneity and regulating immune cell infiltration in CRC requires further clarification.ResultsThe transcriptomic sequencing data of 18 m5C regulators and clinical data of patients with CRC were obtained from The Cancer Genome Atlas (TCGA) and systematically evaluated. We found that 16 m5C regulators were differentially expressed between CRC and normal tissues. Unsupervised cluster analysis was then performed and revealed two distinct m5C modification patterns that yielded different clinical prognoses and biological functions in CRC. We demonstrated that the m5C score constructed from eight m5C-related genes showed excellent prognostic performance, with a subsequent independent analysis confirming its predictive ability in the CRC cohort. Then we developed a nomogram containing five clinical risk factors and the m5C risk score and found that the m5C score exhibited high prognostic prediction accuracy and favorable clinical applicability. Moreover, the CRC patients with low m5C score were characterized by “hot” TME exhibiting increased immune cell infiltration and higher immune checkpoint expression. These characteristics were highlighted as potential identifiers of suitable candidates for anticancer immunotherapy. Although the high m5C score represented the non-inflammatory phenotype, the CRC patients in this group exhibited high level of sensitivity to molecular-targeted therapy.ConclusionOur comprehensive analysis indicated that the novel m5C clusters and scoring system accurately reflected the distinct prognostic signature, clinicopathological characteristics, immunological phenotypes, and stratifying therapeutic opportunities of CRC. Our findings, therefore, offer valuable insights into factors that may be targeted in the development of precision medicine-based therapeutic strategies for CRC.

m5C RNA Methylation Primarily Affects the ErbB and PI3K–Akt Signaling Pathways in Gastrointestinal Cancer

m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer

RNA M5c Methylation Orchestrates BLCA Progression Via Macrophage Reprogramming

Advances in RNA Cytosine-5 Methylation: Detection, Regulatory Mechanisms, Biological Functions and Links to Cancer

Single-cell N6-methyladenosine Regulator Patterns Guide Intercellular Communication of Tumor Microenvironment That Contribute to Colorectal Cancer Progression and Immunotherapy

Emerging Roles of RNA Methylation in Gastrointestinal Cancers

Deciphering the vital roles and mechanism of m5C modification on RNA in cancers

Biological roles of RNA m5C modification and its implications in Cancer immunotherapy

M6a RNA Modification Modulates PI3K/Akt/mTOR Signal Pathway in Gastrointestinal Cancer

Distinct Roles of m5C RNA Methyltransferase NSUN2 in Major Gynecologic Cancers

Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Distinct Roles of m<SUP>5</SUP>C RNA Methyltransferase NSUN2 in Major Gynecologic Cancers

The emerging significance of RNA 5-methylcytosine modification in human cancers

5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs

The Role of RNA M5c Modification in Cancer Metastasis.

RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases

M5c Regulator-Mediated Modification Patterns and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer: One Step Closer to Precision Medicine

RNA 5-Methylcytosine Regulators Contribute to Metabolism Heterogeneity and Predict Prognosis in Ovarian Cancer

Research progress on m5C methylation and its prospects in tumor immunotherapy

M5c-Methylated Lncrna NR_033928 Promotes Gastric Cancer Proliferation by Stabilizing GLS Mrna to Promote Glutamine Metabolism Reprogramming